IMS Health stock jumps after second biggest U.S. IPO of 2014

IMS Health ($IMS) successfully went public last week, raising $1.3 billion in the second biggest U.S. offering of the year. The IPO was priced at $20 a share--above the midpoint of the range--and rose when trading began Friday. IMS' shares closed up 15% on Friday. Most of the cash raised in the IPO will go towards paying off IMS' debt--which was almost $5 billion at the end of the year--and be used for general corporate purposes. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.